Online Reporting Tool

National Target

General

Government

Cameroon

Enter national target title

Objective 11 : Strengthen and promote biosafety risk prevention measures in the context of safeguarding human health, biodiversity and the environment, while supporting research in modern biotechnology and the development of a local pharmaceutical industry.

Description

This objective aims to develop and implement robust measures to prevent the risks associated with the use of modern biotechnologies, taking into account the imperatives of health security, biodiversity and environmental protection, as well as support for local pharmaceutical research and industry.

Alignment

Contribution to global Goals

GBF-G-C. Benefits from the use of genetic resources are shared and substantially increased

Alignment with global targets

Global Targets

Degree of Alignment

GBF-T17. Strengthen biosafety and distribute benefits of biotechnology

High

Which of the “considerations for implementation” in Section C of the GBF have been taken into account in developing this national target, and the actions to implement it

Biodiversity and health

Collective effort towards the targets

Consistency with international agreements or instruments

Cooperation and synergies

National circumstances, priorities and capabilities

Right to development

Science and innovation

Whole-of-government and whole-of-society approach

Please explain how these considerations have been taken into account

Multi-stakeholder sub-national workshops involving sectoral administrations, representatives of decentralized local authorities, representatives of universities, research institutes and researchers, traditional authorities, civil society organizations, in particular women's organizations, representatives of indigenous peoples and the private sector, have made it possible to gather contributions from local stakeholders in order to integrate local realities and national circumstances into the NBSAP II revision process.

Indicators to be used to monitor this national target

Headline indicators

C.1 Monetary benefits received in accordance with applicable internationally agreed access and benefit-sharing instruments

C.2 Non-monetary benefits arising from applicable international access and benefit-sharing instruments

Binary indicators

13.b Number of countries that have taken effective legal, policy, administrative and capacity-building measures at all levels, as appropriate, to ensure the fair and equitable sharing of benefits from the utilization of genetic resources and from digital sequence information on genetic resources, as well as traditional knowledge associated with genetic resources

17.b Number of countries that have taken action to implement biosafety measures as set out in Article 8(g) of the Convention and measures for the handling of biotechnology and the distribution of its benefits as set out in Article 19

Means to implementation and barriers to implementation

Please indicate if additional means of implementation are needed for the attainment of this national target.

Other

Please explain (Additional means of implementation are needed for the attainment of this national target)

The actions and activities are currently being developed, and therefore cannot be yet budgeted.